Product Information
LISDEXAMFETAMINE 70 MG CAPSULE is a generic product labeled by Hikma Pharmaceuticals USA Inc., priced at $2.9234 per EA under NDC 00054037525. Its NADAC has been published 145 times since Sep 20, 2023.
Strength
70 mg/1
Manufacturer
Hikma Pharmaceuticals USA Inc.NDC
00054037525
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
LISDEXAMFETAMINE DIMESYLATEApproval Type
Generic (ANDA)
FDA Application
ANDA202827On Market Since
8/25/2023
Pharmacological Classes
Price Statistics
The NADAC for LISDEXAMFETAMINE 70 MG CAPSULE has been published 145 times since Sep 20, 2023, and over the history we have for it it has declined 7.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $2.9234 per EA |
|---|---|
| All-time high | $7.4828 (Apr 10, 2024) |
| All-time low | $2.8502 (Feb 18, 2026) |
| 52-week high | $4.4387 |
| 52-week low | $2.8502 |
| Median price | $4.2989 |
| Average price | $4.4548 |
| Largest weekly change | +66.2% (Aug 21, 2024) |
| Weeks tracked | 145 |
| Tracking since | Sep 20, 2023 |
Generic Alternatives
The matcher finds 3 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 3 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of LISDEXAMFETAMINE 70 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for LISDEXAMFETAMINE 70 MG CAPSULE, manufactured by Hikma Pharmaceuticals USA Inc., is $2.9234 per EA (NDC 00054037525), effective Jun 24, 2026.
How has the price of LISDEXAMFETAMINE 70 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for LISDEXAMFETAMINE 70 MG CAPSULE has declined 7.4%. It has been tracked across 145 weekly CMS publications since Sep 20, 2023.
What are the highest and lowest recorded NADAC prices for LISDEXAMFETAMINE 70 MG CAPSULE?
Since Sep 20, 2023, the NADAC for LISDEXAMFETAMINE 70 MG CAPSULE has ranged from a low of $2.8502 (Feb 18, 2026) to a high of $7.4828 (Apr 10, 2024), with a median of $4.2989 per EA.
Are there cheaper alternatives to LISDEXAMFETAMINE 70 MG CAPSULE?
3 NADAC-published products share the same active ingredient, strength, and dosage form as LISDEXAMFETAMINE 70 MG CAPSULE, but none are currently priced below it.
Who manufactures LISDEXAMFETAMINE 70 MG CAPSULE?
LISDEXAMFETAMINE 70 MG CAPSULE (NDC 00054037525) is labeled by Hikma Pharmaceuticals USA Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification